HRP921337B1 - Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent - Google Patents

Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent

Info

Publication number
HRP921337B1
HRP921337B1 HRP-945A HRP921337A HRP921337B1 HR P921337 B1 HRP921337 B1 HR P921337B1 HR P921337 A HRP921337 A HR P921337A HR P921337 B1 HRP921337 B1 HR P921337B1
Authority
HR
Croatia
Prior art keywords
carboxy
ethylamino
complex salts
propylamino
hematoporphyrin
Prior art date
Application number
HRP-945A
Other languages
English (en)
Inventor
Alfreda Graczyk
Jerzy Konarski
Original Assignee
Wojskowa Akad Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wojskowa Akad Tech filed Critical Wojskowa Akad Tech
Publication of HRP921337A2 publication Critical patent/HRP921337A2/hr
Publication of HRP921337B1 publication Critical patent/HRP921337B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HRP-945A 1991-10-29 1992-11-24 Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent HRP921337B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL91292220A PL165249B1 (pl) 1991-10-29 1991-10-29 Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
YU94592A YU48961B (sh) 1991-10-29 1992-10-29 Kompleksne soli hematoporfirina i njegovih derivata i njihova sinteza

Publications (2)

Publication Number Publication Date
HRP921337A2 HRP921337A2 (en) 1994-10-31
HRP921337B1 true HRP921337B1 (en) 2000-02-29

Family

ID=20055985

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-945A HRP921337B1 (en) 1991-10-29 1992-11-24 Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent

Country Status (18)

Country Link
US (1) US5451599A (bg)
EP (1) EP0539960B1 (bg)
JP (1) JP3020759B2 (bg)
CN (1) CN1040328C (bg)
BG (1) BG61648B1 (bg)
CA (1) CA2081605C (bg)
CZ (1) CZ281694B6 (bg)
DE (1) DE69217819T2 (bg)
DK (1) DK0539960T3 (bg)
FI (1) FI100243B (bg)
HR (1) HRP921337B1 (bg)
LV (1) LV11952B (bg)
NO (1) NO300499B1 (bg)
PL (1) PL165249B1 (bg)
RU (1) RU2122003C1 (bg)
SI (1) SI9200286B (bg)
UA (1) UA40568C2 (bg)
YU (1) YU48961B (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
GB9606293D0 (en) * 1996-03-26 1996-05-29 William Harvey Research Limite Treatment of cancers and other tumours
BR0115795A (pt) 2000-11-29 2003-08-12 Pci Biotech As Métodos para introduzir uma molécula no citosol de uma célula, para o tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, para estimular uma resposta imune, célula, e, uso de uma molécula de transferência e/ou um agente fotossensibilizante
DK1339862T3 (en) 2000-11-29 2014-02-17 Pci Biotech As PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol
CN104130266A (zh) * 2013-05-02 2014-11-05 中国医学科学院生物医学工程研究所 一种新型原卟啉衍生物及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912M (fr) * 1963-07-24 1964-11-09 Rech S Pharma E R P H A R Soc Dichlorhydrate d'hématoporphyrinate de procaine.
KR910009202B1 (ko) * 1985-10-23 1991-11-04 니혼메디피직스 가부시끼가이샤 포르피린 유도체의 제조방법
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
CN102565846B (zh) * 2011-12-30 2014-05-14 清华大学 蜂窝型热中子探测器

Also Published As

Publication number Publication date
CA2081605C (en) 2002-02-26
NO924151D0 (no) 1992-10-28
JP3020759B2 (ja) 2000-03-15
CA2081605A1 (en) 1993-04-30
CN1071914A (zh) 1993-05-12
CN1040328C (zh) 1998-10-21
YU94592A (sh) 1995-12-04
SI9200286A (en) 1993-06-30
EP0539960A3 (en) 1993-06-16
BG97030A (bg) 1994-03-24
PL165249B1 (pl) 1994-11-30
CZ281694B6 (cs) 1996-12-11
JPH05262775A (ja) 1993-10-12
DK0539960T3 (da) 1997-09-15
LV11952B (en) 1998-06-20
FI924856A0 (fi) 1992-10-26
DE69217819D1 (de) 1997-04-10
DE69217819T2 (de) 1997-09-04
US5451599A (en) 1995-09-19
RU2122003C1 (ru) 1998-11-20
SI9200286B (en) 2001-06-30
HRP921337A2 (en) 1994-10-31
NO300499B1 (no) 1997-06-09
YU48961B (sh) 2003-01-31
EP0539960A2 (en) 1993-05-05
FI100243B (fi) 1997-10-31
PL292220A1 (en) 1993-09-20
EP0539960B1 (en) 1997-03-05
UA40568C2 (uk) 2001-08-15
LV11952A (lv) 1998-01-20
FI924856A (fi) 1993-04-30
BG61648B1 (bg) 1998-02-27
CZ325292A3 (en) 1993-09-15
NO924151L (no) 1993-04-30

Similar Documents

Publication Publication Date Title
DE3375137D1 (en) Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE122004000034I2 (de) Verfahren zur entfernung von Gallsaure von einem Patienten sowie alkylierte zusammensetzungen dafür
CA2152137A1 (en) Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
PT77996B (en) Process of the preparations of mevalonelactone analogs and derivatives thereof and of pharmaceutical compositions containing them
ES8306371A1 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
HRP921337B1 (en) Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent
GR3002155T3 (en) Un-natural ceramide related compounds and preparation thereof
HUT54362A (en) Process for producing cumarin derivatives and pharmaceutical compositions containing them
PT76934B (en) Process for the preparation of novel cetene-thio-acetals
ITRM910327A1 (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
DE3164314D1 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
DE69105786D1 (de) Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
PT90635A (pt) Processo para a preparacao de derivados do acido n-(5,6,7,8-tetra-hidropirido-{2,3-d}pirimidin-6-il-alcanoil)glutamico
CZ228195A3 (en) Derivatives of hydroxymethylfurazancarboxylic acid, process of their preparation, their use for treating cardiovascular diseases and a pharmaceutical composition containing thereof
EP0330413A3 (en) Method for inhibition of scale formation, compositions thereof and method for preparation of such compositions
HU9601701D0 (en) Aromatic hydroxamic acid compounds, process for producing them and their use
RU92004314A (ru) Комплексные соли гематопорфирина и его производных, способ их производства и фармацевтическое средство
DE68902887D1 (de) Propargylguanidin-derivate und verfahren zu deren herstellung.
JPS56156293A (en) Ethylene glycol derivative
LTIP1787A (en) Novel acrylic amide derivatives, aprocess for their preparation, pharmaceutical compositions containing the same and their use in medicine

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: NAPTA" S.A., "NARODOWA AGENCJA FOTODYNAMICZNEJ DIA

ODRP Renewal fee for the maintenance of a patent

Payment date: 20101020

Year of fee payment: 19

PBON Lapse due to non-payment of renewal fee

Effective date: 20111030